SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Shin Bet exposes Iran’s cyber plot: 200 attacks aimed at assassinating Israeli officials

Simply’s Vision Pro app turns Apple’s XR headset into a piano teacher

What drove Pat Gelsinger to step down as Intel CEO? Inside the tumultuous tenure

Full list of Israeli high-tech funding rounds in 2024

Buzz

Most popular

Daily

Weekly

1

"David’s Sling and Iron Dome intercepted more targets than all other air defense systems combined in the past 50 years"

2

Netflix faces $2.75 million class action lawsuit over Mike Tyson and Jake Paul fight glitches

3

November 2024 in Israeli tech funding: $697 million in 17 deals

4

Israeli tech firm Silicom denies Iranian claims of Mossad and Unit 8200 links after cyber breach

5

Cloud security startup Upwind nets $100M in Series A, triples valuation to $900M

Biomed

8 stories about Biomed

תרופות זירת הבריאות

Entera Bio Gives Nasdaq IPO Another Shot

21.05.18|Dror Reich

This is the fourth time since 2014 that the Jerusalem-based biomed company files for an initial public offering on Nasdaq

Pharma Company Opko Health Retracts Decision to Delist From the Tel Aviv Stock Exchange

29.04.18|Racheli Bindman

Dually listed on Nasdaq and TASE, Opko first submitted a request to delist from the TASE in early April

An Israeli Company Wants to Treat Tourette Syndrome With Cannabis

09.04.18|Lilach Baumer

Therapix Biosciences announced the successful completion of phase 2 clinical trial of its cannabinoid-based drug, conducted at Yale University Monday

נאסד"ק וול סטריט

For the Fourth Time, Entera Bio Tries for Nasdaq IPO

08.01.18|Dror Reich

The Jerusalem-based biomed company plans to raise $55 million, with Oppenheimer & Co. as the sole underwriter

Biomed Company Protalix to Lay Off a Fifth of its Workforce

26.11.17|Dror Reich

The Israel-based NYSE American-listed company is currently undergoing a streamlining process

תרופות טבע גלולות תרופה

Entera Bio Files for Nasdaq IPO

12.11.17|Lilach Baumer

The clinical stage company develops treatments mostly for osteoporosis and bone disorders

קולפלנט דיו ביולוגי

Collplant Takes a Step Towards 3D Organ Printing

17.10.17|Lilach Baumer

The Israel-based company develops collagen-based biological ink for 3D organ printing

IPO Hopeful Entera Bio Moves to Better Position

13.09.17|Dror Reich

Clinical-stage company Entera Bio develops pioneering technology for orphan disease hypoparathyroidism

Previous Articles